12-HETE-PE, which can be formed from 12-LOX is removed in the acute phase of peritonitis and reappears in the resolution of acute inflammationZK-192 (oral pharmacokinetics) and related 3-oxa-ATL analog may have a therapeutic function in CD. The gene discussed is SPRR2A; the disease is peritonitis.